154 related articles for article (PubMed ID: 1332190)
1. [New receptor ligands for single-photon emission tomography of the brain].
Schubiger PA
Schweiz Med Wochenschr; 1992 Oct; 122(44):1678-88. PubMed ID: 1332190
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of benzodiazepine receptor binding with PET [11C]iomazenil and SPECT [123I]iomazenil: preliminary results of a direct comparison in healthy human subjects.
Bremner JD; Baldwin R; Horti A; Staib LH; Ng CK; Tan PZ; Zea-Ponce Y; Zoghbi S; Seibyl JP; Soufer R; Charney DS; Innis RB
Psychiatry Res; 1999 Aug; 91(2):79-91. PubMed ID: 10515463
[TBL] [Abstract][Full Text] [Related]
3. [Functional imaging (PET and SPECT) in epilepsy].
Borbély K
Orv Hetil; 2001 Nov; 142(44):2405-14. PubMed ID: 11766233
[TBL] [Abstract][Full Text] [Related]
4. [Benzodiazepine receptor imaging with positron emission tomography and single photon emission tomography].
Bartenstein P; Koepp M
Nervenarzt; 1995 Jun; 66(6):412-21. PubMed ID: 7637827
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters.
Millet P; Graf C; Buck A; Walder B; Ibáñez V
Neuroimage; 2002 Oct; 17(2):928-42. PubMed ID: 12377167
[TBL] [Abstract][Full Text] [Related]
6. Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity [(11)C]Iomazenil in healthy human subjects.
Bremner JD; Horti A; Staib LH; Zea-Ponce Y; Soufer R; Charney DS; Baldwin R
Synapse; 2000 Jan; 35(1):68-77. PubMed ID: 10579810
[TBL] [Abstract][Full Text] [Related]
7. SPECT quantification of benzodiazepine receptor concentration using a dual-ligand approach.
Millet P; Graf C; Moulin M; Ibáñez V
J Nucl Med; 2006 May; 47(5):783-92. PubMed ID: 16644748
[TBL] [Abstract][Full Text] [Related]
8. Receptor imaging by positron emission tomography and single-photon emission computed tomography.
Frost JJ
Invest Radiol; 1992 Dec; 27 Suppl 2():S54-8. PubMed ID: 1334949
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography studies of brain receptors.
Mazière B; Mazière M
Fundam Clin Pharmacol; 1991; 5(1):61-91. PubMed ID: 1676695
[TBL] [Abstract][Full Text] [Related]
10. Receptor imaging by PET and SPECT: focus on the opiate receptor.
Frost JJ
J Recept Res; 1993; 13(1-4):39-53. PubMed ID: 8095556
[TBL] [Abstract][Full Text] [Related]
11. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments.
Laruelle M; Baldwin RM; Rattner Z; al-Tikriti MS; Zea-Ponce Y; Zoghbi SS; Charney DS; Price JC; Frost JJ; Hoffer PB
J Cereb Blood Flow Metab; 1994 May; 14(3):439-52. PubMed ID: 8163586
[TBL] [Abstract][Full Text] [Related]
12. [Parametric images of central-type benzodiazepine receptor binding and ligand transport by two SPECT scans of 123I-iomazenil: relative quantification without blood data].
Onishi Y; Yonekura Y; Tanaka F; Nishizawa S; Okazawa H; Ishizu K; Fujita T; Konishi J; Mukai T
Kaku Igaku; 1996 Sep; 33(9):953-63. PubMed ID: 8921663
[TBL] [Abstract][Full Text] [Related]
13. Quantification of GABAA receptors in the rat brain with [(123)I]Iomazenil SPECT from factor analysis-denoised images.
Tsartsalis S; Moulin-Sallanon M; Dumas N; Tournier BB; Ghezzi C; Charnay Y; Ginovart N; Millet P
Nucl Med Biol; 2014 Feb; 41(2):186-95. PubMed ID: 24405841
[TBL] [Abstract][Full Text] [Related]
14. Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: preliminary findings from an 123I-iomazenil single photon emission tomography study.
Lingford-Hughes AR; Acton PD; Gacinovic S; Boddington SJ; Costa DC; Pilowsky LS; Ell PJ; Marshall EJ; Kerwin RW
Alcohol Clin Exp Res; 2000 Sep; 24(9):1449-55. PubMed ID: 11003213
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
Kegeles LS; Mann JJ
Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
[TBL] [Abstract][Full Text] [Related]
16. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms.
Abi-Dargham A; Laruelle M; Seibyl J; Rattner Z; Baldwin RM; Zoghbi SS; Zea-Ponce Y; Bremner JD; Hyde TM; Charney DS
J Nucl Med; 1994 Feb; 35(2):228-38. PubMed ID: 8294990
[TBL] [Abstract][Full Text] [Related]
17. Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects.
Woods SW; Seibyl JP; Goddard AW; Dey HM; Zoghbi SS; Germine M; Baldwin RM; Smith EO; Charney DS; Heninger GR
Psychiatry Res; 1992 Aug; 45(2):67-77. PubMed ID: 1336860
[TBL] [Abstract][Full Text] [Related]
18. Where have we got to with neuroreceptor mapping of the human brain?
Mazière B; Mazière M
Eur J Nucl Med; 1990; 16(11):817-35. PubMed ID: 2170141
[TBL] [Abstract][Full Text] [Related]
19. Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.
Delforge J; Pappata S; Millet P; Samson Y; Bendriem B; Jobert A; Crouzel C; Syrota A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):284-300. PubMed ID: 7860662
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil.
Abi-Dargham A; Gandelman M; Zoghbi SS; Laruelle M; Baldwin RM; Randall P; Zea-Ponce Y; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1995 Feb; 36(2):167-75. PubMed ID: 7830108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
